Sular
NDC 70515-500, nisoldipine, tablet, film coated, extended release, from Covis Pharma US, Inc.
- Product NDC
- 70515-500
- Status
- Listed
- Labeler
- Covis Pharma US, Inc
- Dosage form
- TABLET, FILM COATED, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA020356
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/70515-500 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- NISOLDIPINE8.5 mg/1
Pharmacologic classes
Calcium Channel Antagonists [MoA]; Decreased Blood Pressure [PE]; Dihydropyridine Calcium Channel Blocker [EPC]; Dihydropyridines [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 70515-500-10 | 70515050010 | 1 BOTTLE in 1 CARTON (70515-500-10) / 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/589157fa-d129-4de3-be3d-e0e1c22c5873
Use it
Look up 70515-500 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70515-500 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70515-500. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.